Genomics in Medical Technology
Navigation Links
Genomics in Medical Technology
... a novel collaborative research agreement with the genomics Institute of the Novartis Research Foundation ... and JDRF volunteers.
About GNF
The genomics Institute of the Novartis Research Foundation ... cut across the life sciences, and include genomics and proteomics tools, medicinal chemistry, ...
... Sun Health Research Institute, Translational genomics Research Institute and the University of Arizona. ... . About TGen The Translational genomics Research Institute (TGen) is a Phoenix, ... Sun Health Research Institute, the Translational genomics Research Institute (TGen) and the University of ...
... February 12 /PRNewswire-FirstCall/ -- Rosetta genomics Ltd. (Nasdaq: ROSG ) reported today the first ... Inc. About Rosetta genomics Rosetta genomics (Nasdaq: ROSG ) is a leading developer of ...
... test," noted Dr. Dalia Cohen, Rosetta genomics Chief Scientific Office." miRview(TM) squamous is ... samples had been misclassified. Rosetta genomics will host a conference call with a simultaneous ... strategy for many diseases. About Rosetta genomics ...
... studies. In phase one of the project, Complete genomics will use its proprietary DNA sequencing ... Complete Genomics Founded in 2006, Complete genomics is a California company that has developed a novel approach to sequencing human DNA. Complete genomics plans to combine its proprietary third-generation ...
... Earlier This Year Rosetta genomics is Expecting to Launch miRview(TM) Squamous Later ... biomarkers identified by the company, Rosetta genomics has developed a test which differentiates ... and discovery. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ...
... and who meet the eligibility criteria. Rosetta genomics expects this test to be submitted for ... diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... the first step in the transformation of Rosetta genomics into a commercial diagnostics company," said Amir ... as other lung cancers at central labs. Rosetta genomics expects two additional tests based on its ... diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ...
... Rabin Medical Center, and Chairman of the Rosetta genomics Medical Advisory Board. " There is true unmet ... the globe. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... Jersey, May 16 /PRNewswire-FirstCall/ -- Rosetta genomics Ltd. (Nasdaq: ROSG ), a leader in the development ... implications. In the present study, Rosetta genomics and collaborators use microRNAs as biomarkers for ... diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ...
... California, Irvine School of Medicine Rosetta genomics Expects Three Tests Applying its MicroRNA ... About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... inhibitor, in the United States. Rosetta genomics expects two additional tests based on its ... About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... diagnostic strategy for many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of microRNA. Founded in 2000, ... on its strong IP position and proprietary platform technologies, Rosetta genomics is working on the application of these technologies in the development of ...
... diagnostic strategy for many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of microRNA. Founded in 2000, ... on its strong IP position and proprietary platform technologies, Rosetta genomics is working to develop a full range of microRNA-based diagnostic and ...
... ST. LOUIS, June 11 /PRNewswire/ -- Orion genomics announced today that the company entered into a worldwide exclusive ... size of more than 81 million people." About Orion Genomics Orion genomics develops epigenetic research tools and molecular diagnostic products to ...
... diagnostic strategy for many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of microRNAs. Founded in 2000, ... on its strong IP position and proprietary platform technologies, Rosetta genomics is working on the application of these technologies in the development of ...
... by the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG). Warfarin (also called Coumadin) is a drug prescribed to help ... of the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is coordinating the "CReating ...
... is primarily a molecular diagnostics business that is using proprietary genomics and proteomics discovery platforms to identify and validate novel ... developing new diagnostic products outside of this alliance. Through its genomics and proteomics research efforts, Celera is also discovering and validating ...
... by the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG). Warfarin (also called Coumadin) is a drug prescribed to help ... of the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is coordinating the "CReating ...
... Sun Health Research Institute, Translational genomics Research Institute and the University of Arizona. ... . About TGen The Translational genomics Research Institute (TGen) is a Phoenix, ... Sun Health Research Institute, the Translational genomics Research Institute (TGen) and the University of ...
Advance in Bowel Cancer Test Research
... and Australian healthcare company, Clinical genomics Pty Ltd - designed to develop an improved ... Professor Young says. The CEO of Clinical genomics Pty Ltd, Lawrence La Pointe, says if a more ... 400 995 027 Lawrence La Pointe Clinical genomics Pty Ltd E: larry@clinicalgenomics.com ...First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
... Malaysia, May 20 /PRNewswire/ -- Synthetic genomics Inc. (SGI), a privately held company applying ... Asiatic Development Berhad. About Synthetic genomics Inc. SGI, a privately held company founded in ... and environment challenges. Advances in synthetic genomics present limitless applications in a variety of ...Clinical Genomics Continues Progress in Developing Biomarker Portfolio for Colorectal Cancer Testing
... SYDNEY, April 29 /PRNewswire/ -- Clinical genomics Pty Ltd, an Australian biotechnology company, ... early onset of colorectal cancer. Clinical genomics was awarded the payments after successfully ... [1]American Cancer Society About Clinical genomics ...Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
... and diagnostic company, and Rosetta genomics Ltd. (Nasdaq: ROSG ), an innovative molecular ... strategy for many diseases. About Rosetta genomics Rosetta genomics is a leading molecular diagnostics company ...... February 12 /PRNewswire-FirstCall/ -- Rosetta genomics Ltd. (Nasdaq: ROSG ) reported today the first ... Inc. About Rosetta genomics Rosetta genomics (Nasdaq: ROSG ) is a leading developer of ...
... test," noted Dr. Dalia Cohen, Rosetta genomics Chief Scientific Office." miRview(TM) squamous is ... samples had been misclassified. Rosetta genomics will host a conference call with a simultaneous ... strategy for many diseases. About Rosetta genomics ...
... studies. In phase one of the project, Complete genomics will use its proprietary DNA sequencing ... Complete Genomics Founded in 2006, Complete genomics is a California company that has developed a novel approach to sequencing human DNA. Complete genomics plans to combine its proprietary third-generation ...
... Earlier This Year Rosetta genomics is Expecting to Launch miRview(TM) Squamous Later ... biomarkers identified by the company, Rosetta genomics has developed a test which differentiates ... and discovery. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ...
Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
... This Proprietary Technology, Rosetta genomics is Currently Developing a ... many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...Gene That Causes Childhood Cancer Neuroblastoma Is Found
... analytic equipment at the Center for Applied genomics at Children's Hospital. By employing genome-wide ... the Carly Hillman Fund. The Center for Applied genomics at The Children's Hospital of Philadelphia also ... M.D., Ph.D., director of the Center for Applied genomics at Children's Hospital. The above co-authors are ...... and who meet the eligibility criteria. Rosetta genomics expects this test to be submitted for ... diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... the first step in the transformation of Rosetta genomics into a commercial diagnostics company," said Amir ... as other lung cancers at central labs. Rosetta genomics expects two additional tests based on its ... diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ...
... Rabin Medical Center, and Chairman of the Rosetta genomics Medical Advisory Board. " There is true unmet ... the globe. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... Jersey, May 16 /PRNewswire-FirstCall/ -- Rosetta genomics Ltd. (Nasdaq: ROSG ), a leader in the development ... implications. In the present study, Rosetta genomics and collaborators use microRNAs as biomarkers for ... diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ...
... California, Irvine School of Medicine Rosetta genomics Expects Three Tests Applying its MicroRNA ... About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
... inhibitor, in the United States. Rosetta genomics expects two additional tests based on its ... About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies, Rosetta genomics is working on the application of these ...
Gene Hunters Fine-Tune Marker for Common Obesity Gene
... PHILADELPHIA, March 12 /PRNewswire-USNewswire/ -- genomics researchers, seeking to replicate another group's ... Ph.D., both of the Center for Applied genomics of The Children's Hospital of Philadelphia, was ... single nucleotide polymorphisms, or SNPs. For genomics researchers, said Grant, the findings mean that ...Personalized Medicine - The Genomic Revolution in Cardiac Care
... and implications around the growing forces of genomics and personalized medicine in cardiology. This ... the current status and future directions of the genomics of atherosclerotic cardiovascular disease, heart ... agenda features luminaries in the field of genomics who will explore the state of ...Diabetes Gene Raises Odds of Lower Birth Weight
... leader Struan F.A. Grant, Ph.D., a researcher at the Center for Applied genomics of The Children's Hospital of Philadelphia. "This gene variant carries a ... co-leader Hakon Hakonarson, Ph.D., director of the Center for Applied genomics at Children's Hospital, investigated 20 gene locations previously reported ...Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
... pleased to be a part of this research effort because working with Sirius genomics will help translate genomic biomarker research in sepsis from the lab ... combined. About Sirius Genomics: www.siriusgenomics.com Sirius genomics is a drug-enabling company that develops pharmacogenomic (PGx) diagnostics ...Autism Genes Discovered; Help Shape Connections Among Brain Cells
... leader Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied genomics at The Children's Hospital of Philadelphia. He is on the faculty of the ... of specific genes that give rise to cancers. Our extensive pediatric genomics program has pinpointed particular genes and biological pathways, and this ...Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
... The study was conducted by SM in collaboration with the Translational genomics Research Institute's Pharmaceutical genomics Division in Scottsdale, Arizona. "This study has identified certain ...Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project
... to amplify DNA samples for The Cancer Atlas Genome Project. Rubicon genomics was selected to amplify and standardize total genomic DNA from 3,000 ... or (734) 368-1705. About IGC The International genomics Consortium (IGC) is a non-profit medical research foundation established ...... diagnostic strategy for many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of microRNA. Founded in 2000, ... on its strong IP position and proprietary platform technologies, Rosetta genomics is working on the application of these technologies in the development of ...
febit and TGen Collaborate to Study New DNA Capture Method
... HEIDELBERG, Germany, Aug. 14 /PRNewswire/ -- febit and the Translational genomics Research Institute (TGen) today announced the formation of a collaboration ... of applications. http://www.febit.com About TGen The Translational genomics Research Institute (TGen) is a non-profit 501(c)(3) organization dedicated ...... diagnostic strategy for many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of microRNA. Founded in 2000, ... on its strong IP position and proprietary platform technologies, Rosetta genomics is working to develop a full range of microRNA-based diagnostic and ...
... ST. LOUIS, June 11 /PRNewswire/ -- Orion genomics announced today that the company entered into a worldwide exclusive ... size of more than 81 million people." About Orion Genomics Orion genomics develops epigenetic research tools and molecular diagnostic products to ...
... diagnostic strategy for many diseases. About Rosetta Genomics Rosetta genomics (Nasdaq: ROSG ) is a leader in the field of microRNAs. Founded in 2000, ... on its strong IP position and proprietary platform technologies, Rosetta genomics is working on the application of these technologies in the development of ...
Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC)
... genomics improves our ability to target experimental cancer treatments A ... that leads to the development of HCC. Applying the technologies of genomics and microarrays, scientists have discovered that there are a number of ...Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
... Cancer - ST. LOUIS, Dec. 20 /PRNewswire/ -- Orion genomics announced today the discovery and validation of the most frequent DNA ... programs in cancers of the bladder, breast, lung, ovaries and colon. Orion genomics is located in the Center for Emerging Technologies in St. Louis. For more ...ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
... the mechanism of leukocyte replenishment. About TGen The Translational genomics Research Institute (TGen), a non-profit 501(c)(3) organization, is focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising ...... by the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG). Warfarin (also called Coumadin) is a drug prescribed to help ... of the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is coordinating the "CReating ...
... is primarily a molecular diagnostics business that is using proprietary genomics and proteomics discovery platforms to identify and validate novel ... developing new diagnostic products outside of this alliance. Through its genomics and proteomics research efforts, Celera is also discovering and validating ...
... by the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG). Warfarin (also called Coumadin) is a drug prescribed to help ... of the Harvard Medical School-Partners HealthCare Center for Genetics and genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is coordinating the "CReating ...
Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
... Because this culture collection holds considerable potential for product innovation, DANONE RESEARCH using state-of-the-art technologies such as genomics and robotics to select the probiotic bacteria of the future is carefully studying it. For more information, please visit www.danone.com/?lang=en , ...deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
... of Bonn, the University Medical Center of Utrecht, Nijmegen Medical Center, the University of Verona, the Duke University Center for Population genomics and Pharmacogenetics and the University of Sichuan, China. Follow up cohorts included those from Aarhus University, the National Serum Institute, and .../C O R R E C T I O N -- Agendia B.V./
... the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets ...More Gene Mutations Linked to Autism Risk
... are more likely to directly disrupt biological functions," said study leader Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied genomics at The Children's Hospital of Philadelphia and associate professor of Pediatrics at the University of Pennsylvania School of Medicine. "We ...Other ContentsexpectorantemergenciesemergenciesburningburningburningburningextremityextremityextremityextremityexudatefaceliftconditionsconditionsconditionsconditionsconditionsconditionsconditionsconditionsconditionsconditionsmovementsmovementsmovementsmovementsmovementsmovementsmovementsmovementsOther TagsContaminationContaminationMigrantForestForestCubanUnion
(Date:12/16/2009)... molecules form an intricate network of interactions. Today,s ... individual molecular reactions outside the cells. Since molecular ... the laboratory, scientists suspect that the kinetics of ... external probes. We expected the cellular reaction speed ... Braun. "However, our novel optical approach showed that ...
(Date:12/16/2009)... A University of Maryland School of Medicine researcher will ... nation,s most prominent scientists in the field of stem ... and Preventive Medicine, was chosen by the National Heart, ... of this consortium of national experts, which will be ... center will be funded by a $30 million grant ...
(Date:12/16/2009)... Dec. 3 BIO-key International, Inc. ... wireless public safety and finger-based biometric identification ... shareholders at a Special Shareholder Meeting held ... Law Enforcement Division to Interact911 Mobile Systems ... cast in favor and 1.2% were opposed. ...
Breaking Biology News(10 mins):Looking for the heartbeat of cellular networks 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Genomic Health to Present at Piper Jaffray Health Care Conference 14955 1Genomic Health to Present at Piper Jaffray Health Care Conference 14955 2Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 1Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 2Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6495 1Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6495 2(Date:12/16/2009)... CLEVELAND -- December 16, 2009 -- Every year ... are diagnosed, and 57,000 patients die of the disease, ... cancer among adults, after lung cancer. , As researchers ... colorectal cancer -- simultaneously generating thousands of studies producing ... professor and researcher of cancer and genetics at Case ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering at Walter ... can be a particularly difficult time. Wounded soldiers ... ever on the healing power of connecting with family ... easier for Walter Reed patients as Verizon Wireless donated ... of minutes of holiday talk time for 2,500 recovering ...
(Date:12/16/2009)... that increase susceptibility to disease , , WEDNESDAY, Dec. ... increased susceptibility to leprosy have been identified by ... who analyzed more than 10,000 DNA samples from ... their discovery highlights the important role that the ... leprosy. , "Though leprosy is not common, the ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
(Date:12/16/2009)... of Digital Pen and Paper technology and the provider of ... announced that it is ranked among the Fastest Growing Technology ... , ... (PRWEB) December 16, 2009 ... the capture, digitalization and management of handwritten data. Kayentis targets ...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:Leprosy Genes Identified 2Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2[0] New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer'[0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital[0] Leprosy Genes Identified[0] New study links DHA type of omega-3 to better nervous-system function[0] With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009
RevisedLumpingContaminationMigrantTenurePrecautionaryUnpopularitySupercentenarianForestCubanUnionTravailsEnbrelrAccessibility
Other Tagsillness 2illness 3illness 4illness 5illness 6illness 7illness 8illness 9illness 10breastfeeding 2breastfeeding 3breastfeeding 4mosquito 2mosquito 3mosquito 4mosquito 5mosquito 6mosquito 7mosquito 8mosquito 9closer 2closer 3closer 4closer 5closer 6closer 7closer 8closer 9closer 10foods 2foods 3foods 4foods 5foods 6foods 7foods 8foods 9foods 10functional 2functional 3functional 4functional 5functional 6functional 7functional 8functional 9functional 10silent 2military 2military 3dairy 2option 2option 3option 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |